Company · CIK 1358403
BELLICUM PHARMACEUTICALS, INC
Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26
| CIK | 1358403 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | TX |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-03-20 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-209012 | 2016-01-15 | 2024-02-26 | 5 | |
| 333-219020 | 2017-06-28 | 2024-02-26 | 3 | |
| 333-219021 | 2017-06-28 | 2024-02-26 | 5 | |
| 333-226652 | 2018-08-07 | 2024-02-26 | 4 | |
| 333-232771 | 2019-07-23 | 2024-02-26 | 6 | |
| 333-264939 | 2022-05-13 | 2024-02-26 | 3 | |
| 333-200328 | 2014-11-18 | 2014-12-18 | 4 |
Filings
31| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-02-26 | EFFECTDeclared effective | 333-264939 | 9999999995-24-000539 |
| 2024-02-26 | EFFECTDeclared effective | 333-232771 | 9999999995-24-000537 |
| 2024-02-26 | EFFECTDeclared effective | 333-226652 | 9999999995-24-000536 |
| 2024-02-26 | EFFECTDeclared effective | 333-219021 | 9999999995-24-000535 |
| 2024-02-26 | EFFECTDeclared effective | 333-219020 | 9999999995-24-000534 |
| 2024-02-26 | EFFECTDeclared effective | 333-209012 | 9999999995-24-000533 |
| 2022-05-23 | EFFECTDeclared effective | 333-264939 | 9999999995-22-001569 |
| 2022-05-13 | S-3Shelf registered | 333-264939 | 0001628280-22-014332 |
| 2020-10-30 | 424B5Shelf takedown | 333-232771 | 0001193125-20-282788 |
| 2019-08-19 | 424B5Shelf takedown | 333-232771 | 0001193125-19-224574 |
| 2019-08-16 | 424B5Shelf takedown | 333-232771 | 0001193125-19-222902 |
| 2019-07-30 | EFFECTDeclared effective | 333-232771 | 9999999995-19-001735 |
| 2019-07-23 | S-3Shelf registered | 333-232771 | 0001193125-19-200072 |
| 2018-10-05 | 424B5Shelf takedown | 333-226652 | 0001193125-18-294717 |
| 2018-08-23 | EFFECTDeclared effective | 333-226652 | 9999999995-18-002182 |
| 2018-08-07 | S-3Shelf registered | 333-226652 | 0001193125-18-241251 |
| 2018-04-18 | 424B5Shelf takedown | 333-219021 | 0001193125-18-121163 |
| 2018-04-16 | 424B5Shelf takedown | 333-219021 | 0001193125-18-118701 |
| 2017-07-12 | EFFECTDeclared effective | 333-219021 | 9999999995-17-001797 |
| 2017-07-12 | EFFECTDeclared effective | 333-219020 | 9999999995-17-001796 |
| 2017-06-28 | S-3Shelf registered | 333-219021 | 0001358403-17-000121 |
| 2017-06-28 | S-3Shelf registered | 333-219020 | 0001358403-17-000120 |
| 2017-03-24 | 424B5Shelf takedown | 333-209012 | 0001193125-17-095587 |
| 2017-03-22 | 424B5Shelf takedown | 333-209012 | 0001193125-17-092300 |
| 2016-02-01 | EFFECTDeclared effective | 333-209012 | 9999999995-16-003639 |
| 2016-01-15 | S-3Shelf registered | 333-209012 | 0001358403-16-000143 |
| 2014-12-18 | 424B4Final prospectus | 333-200328 | 0001193125-14-446724 |
| 2014-12-17 | EFFECTDeclared effective | 333-200328 | 9999999995-14-003723 |
| 2014-12-09 | S-1/AAmendment | 333-200328 | 0001193125-14-436933 |
| 2014-11-18 | S-1Registration filed | 333-200328 | 0001193125-14-416804 |
| 2014-10-17 | DRSDraft made public | 377-00821 | 0000950123-14-010304 |